Skip Standard Navigation Links
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
peer-reviewed.gif (582 bytes)
eid_header.gif (2942 bytes)
Past Issue

Vol. 11, No. 9
September 2005

Adobe Acrobat logo

EID Home | Ahead of Print | Past Issues | EID Search | Contact Us | Announcements | Suggested Citation | Submit Manuscript

PDF Version | Comments Comments | Email this article Email this article



Acknowledgments
References
Table

Letter

Asymptomatic Yersinia pestis Infection, China

Min Li,*1 Yajun Song,†1 Bei Li,† Zuyun Wang,* Ronghai Yang,* Lingxiao Jiang,† and Ruifu Yang†Comments
*Qinghai Institute for Endemic Diseases Prevention and Control, Xining, People's Republic of China; and †Beijing Institute of Microbiology and Epidemiology, Beijing, People's Republic of China

Suggested citation for this article


To the Editor: Plague is one of the oldest identifiable diseases. Modern public health measures and effective antimicrobial treatments have led to a decrease in plague cases worldwide. However, plague remains endemic in many natural foci. Since the early 1990s, the World Health Organization (WHO) has reported a steadily increasing trend in human plague cases, which has resulted in the recognition of plague as a reemerging disease (1). The emergence of antimicrobial drug–resistant strains of Yersinia pestis, along with an increasing number of plague cases, remind us that plague still poses a serious public health threat (2,3). In China, human cases of plague have been reported to WHO nearly every year from 1989 to 2003; these account for 9.5% of cases and 15.5% of deaths from this disease in Asia (1). Human cases of plague in China are usually caused by contact with plague-infected rodents. Here, we report the results of a serologic survey by using 3 methods (passive hemagglutination assay, Western blot, and protein microarray analysis) in marmot hunters in Qinghai Province, China.

One hundred twenty serum samples were collected in 2 villages in Huangyuan County, Qinghai Province, from marmot hunters (63 samples) and their family members (57 samples); none had a history of fever in the past 2 years. One hundred nineteen serum samples were collected from persons with no history of marmot hunting in 2 nearby counties in Qinghai Province in which plague was not endemic. Thirty serum samples were collected from persons in Beijing and used as negative controls.

All serum samples were initially screened with a passive hemagglutination assay to detect immunoglobulin (Ig) G antibody against F1 antigen of Y. pestis, by using a standard protocol (4). We then used an F1 antigen–based Western blot to analyze all serum samples. The protein microarray analysis was performed with 149 purified recombinant proteins of Y. pestis (5).

The results of the serologic survey are summarized in the Table. The passive hemagglutination assay showed 17 positive samples in the marmot hunter population. None of the control serum samples were positive for F1 antigen in this assay. Western blot identified 9 additional positive samples in the marmot hunter population, resulting in a seropositivity rate of 21.7% (26/120). We also found positive samples in 4 (3.4%) of 119 serum samples by using Western blot in persons from areas in which plague was not endemic. Identical results were also obtained by using protein microarray analysis, which validated the results of Western blot.

Previous studies have shown that plague antibodies were more prevalent in males in the exposed population, and differences in the age, sex, or ethnic group of plague patients are the result of variations in exposure to the pathogen, not intrinsic factors (6,7). Our study showed that in the marmot hunter population, the plague seropositivity rate was significantly higher in males (36.8%, 25/68) than in females (2.0%, 1/52, p<0.01). Among the marmot hunter population, 63 (92.6%) of 68 males were hunters. Plague antibodies were also more prevalent in marmot hunters (39.7%, 25/63) than in their family members (1.8%, 1/57, p<0.01).

This is the first serologic survey of plague in the marmot hunter population. The plague seropositivity rate of 21.7% (26/120) in hunters and their families is much higher than the 3.4% (4/119) in the population from regions in which plague was not endemic (p<0.01). Seroprevalence in marmot hunters was even higher (39.7%), which suggests that marmot hunting is a risk factor for plague infection.

The marmot (Marmota himalayana) is the main host of Y. pestis in Qinghai Province. Plague-infected marmots are more easily captured by hunters. When persons hunt and butcher marmots without any effective protection, Y. pestis can be transmitted through tiny wounds in the skin, by bites of infected fleas, or by the respiratory route. Asymptomatic plague infection in marmot hunters might be explained by prophylactic use of antimicrobial drugs. Most hunters usually take sulfamethoxazole or tetracycline as a prophylactic measure. Even if the hunters were infected with Y. pestis, they would likely not develop symptomatic plague. However, if the antimicrobial drugs are not effective or hunters do not use prophylaxis, symptomatic infections will occur. Most reported human cases of plague in Qinghai Province were caused by hunting or butchering marmots, as shown by a recent outbreak of plague in October 2004 in Qinghai, in which 19 cases were reported and 8 persons died (M. Li et al., unpub. data).

Acknowledgments

We thank Jin Wang, Junxing Yang, Dongsheng Zhou, Zongmin Du, Zhaobiao Guo, and Junhui Zhai for technical assistance.

This work was supported by the National Natural Science Foundation of China (30430620).

References

  1. World Health Organization. Human plague in 2002 and 2003. Wkly Epidemiol Rec. 2004;79:301–6.
  2. Galimand M, Guiyoule A, Gerbaud G, Rasoamanana B, Chanteau S, Carniel E, et al. Multidrug resistance in Yersinia pestis mediated by a transferable plasmid. N Engl J Med. 1997;337:677–80.
  3. Guiyoule A, Gerbaud G, Buchrieser C, Galimand M, Rahalison L, Chanteau S, et al. Transferable plasmid-mediated resistance to streptomycin in a clinical isolate of Yersinia pestis. Emerg Infect Dis. 2001;7:43–8.
  4. Cavanaugh DC, Thorpe BD, Bushman JB, Nicholes PS, Rust JH Jr. Detection of an enzootic plague focus by serological methods. Bull World Health Organ. 1965;32:197–203.
  5. Li B, Jiang L, Song Q, Yang J, Chen Z, Guo Z, et al. Protein microarray for profiling antibody responses to Yesinia pestis live vaccine. Infect Immun. 2005:73:3734–9.
  6. Chanteau S, Ratsitorahina M, Rahalison L, Rasoamanana B, Chan F, Boisier P, et al. Current epidemiology of human plague in Madagascar. Microbes Infect. 2000;2:25–31.
  7. Boisier P, Rahalison L, Rasolomaharo M, Ratsitorahina M, Mahafaly M, Razafimahefa M, et al. Epidemiologic features of four successive annual outbreaks of bubonic plague in Mahajanga, Madagascar. Emerg Infect Dis. 2002;8:311–6.

 

Table. Analysis of sera for plague antibody by 3 methods


Method*

Marmot hunter population, no. positive/no. tested (%)

Population from nonendemic areas, no. positive/no. tested (%)



Male

Female

Total

Male

Female

Total


PHA

16/68 (23.5)

1/52 (1.9)

17/120 (14.2)

0/60 (0)

0/59 (0)

0/119 (0)

WB

25/68 (36.8)

1/52 (1.9)

26/120 (21.7)

3/60 (5.0)

1/59 (1.7)

4/119 (3.4)

PMA

25/68 (36.8)

1/52 (1.9)

26/120 (21.7)

3/60 (5.0)

1/59 (1.7)

4/119 (3.4)


*PHA, passive hemagglutination assay; WB, Western blot; PMA, protein microarray analysis.

1These authors contributed equally to this study.

 

Suggested citation for this article:
Li M, Song Y, Li B, Wang Z, Yang R, Jiang L, et al. Asymptomatic Yersinia pestis infection, China [letter]. Emerg Infect Dis [serial on the Internet]. 2005 Sep [date cited]. Available from http://www.cdc.gov/ncidod/EID/vol11no09/04-1147.htm

   
     
   
Comments to the Authors

Please use the form below to submit correspondence to the authors or contact them at the following address:

Ruifu Yang, State Key Laboratory of Pathogens and Biosecurity, Laboratory of Analytical Microbiology, National Center for Biomedical Analysis, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, People's Republic of China; fax: 86-10-8382-0748; email: yangrf@nic.bmi.ac.cn

Please note: To prevent email errors, please use no web addresses, email addresses, HTML code, or the characters <, >, and @ in the body of your message.

Return email address optional:


 


Comments to the EID Editors
Please contact the EID Editors at eideditor@cdc.gov

Email this article

Please note: To prevent email errors, please use no web addresses, email addresses, HTML code, or the characters <, >, and @ in the body of your message.

Your email:

Your friend's email:

Message (optional):

 

 

 

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page posted August 10, 2005
This page last reviewed August 19, 2005

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention